renzapride has been researched along with Constipation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scarpellini, E; Tack, J | 1 |
| Cremonini, F; Hickling, R; Lembo, AJ; Meyers, N | 1 |
| Adam, B; Gerken, G; Liebregts, T | 1 |
| Burton, D; Camilleri, M; Zinsmeister, AR | 1 |
| Baxter, K; Burton, D; Camilleri, M; Fox, J; Foxx-Orenstein, A; McKinzie, S; Thomforde, G; Zinsmeister, AR | 1 |
| Bloor, JS; Horne, MC; Meyers, NL; Middleton, SJ; Palmer, RM; Piessevaux, H; Tack, J | 1 |
| George, AM; Hickling, RI; Meyers, NL | 1 |
3 review(s) available for renzapride and Constipation
| Article | Year |
|---|---|
Renzapride: a new drug for the treatment of constipation in the irritable bowel syndrome.
Topics: Animals; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Constipation; Gastrins; Humans; Irritable Bowel Syndrome; Motilin | 2008 |
[New drugs for the treatment of constipation].
Topics: Alprostadil; Benzamides; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Cathartics; Chloride Channel Agonists; Constipation; Humans; Irritable Bowel Syndrome; Lubiprostone; Peptides; Randomized Controlled Trials as Topic; Receptors, Guanylate Cyclase-Coupled; Receptors, Serotonin, 5-HT4 | 2010 |
Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations.
Topics: Adult; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Chenodeoxycholic Acid; Clinical Trials, Phase II as Topic; Colonic Diseases; Constipation; Controlled Clinical Trials as Topic; Cross-Over Studies; Diarrhea; Female; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Male; Middle Aged; Pentanoic Acids; Peptides; Radionuclide Imaging; Serotonin Antagonists | 2013 |
4 trial(s) available for renzapride and Constipation
| Article | Year |
|---|---|
Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation - a double-blind, randomized, placebo-controlled, study.
Topics: Adolescent; Adult; Aged; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Constipation; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Middle Aged; Quality of Life; Serotonin Antagonists; Treatment Outcome; Young Adult | 2010 |
Effect of renzapride on transit in constipation-predominant irritable bowel syndrome.
Topics: Adult; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Colon; Constipation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Emptying; Gastrointestinal Transit; Humans; Intestine, Small; Irritable Bowel Syndrome; Male; Serotonin Antagonists | 2004 |
Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome.
Topics: Adult; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Constipation; Dose-Response Relationship, Drug; Female; Gastrointestinal Motility; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Pilot Projects; Serotonin Antagonists; Single-Blind Method; Treatment Outcome | 2006 |
Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome--multicentre, randomized, placebo-controlled, double-blind study in primary healthcare setting.
Topics: Adult; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Constipation; Female; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Placebos; Primary Health Care; Serotonin Antagonists | 2008 |